₂P Sander

Summary for 2004 [at-glance overview of P Sander work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author P Sander. According to available data, in 2004 P Sander published at least 2 articles. This work was completed in collaboration with several authors including Altmeyer, P and Keller, C. Many other authors have collaborated with P Sander as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that P Sander professional interests are focused around "vs ml min", "ml min vs" and "min vs ml". These might also be referred to as "ml min", "hiv-infected patients" or "vs ml". Statistical analysis shows that P Sander's writing is likely to contains terms "min", "ml", "vs", "lipoprotein", "tuberculosis" and "lspa".

Unfortunately, there is not enough information to establish P Sander affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for P Sander]

Do you know P Sander who matches the profile above? Click the photo and let us know!

Alternative names (2) [other authors with names similar to P Sander]

₂₆Sander, Peter, ₁₀Sander, Pia

Year 2004 Charts [P Sander frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of P Sander publication and funding history for the range of years]

Emails (2) [email addresses extracted from P Sander affiliations]

hidden to prevent spam, click here to reveal

P Sander Coauthors (13) [all coauthors with the number of joint publications]

1

1

1

1

1

₅Brockmeyer, Norbert H

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (2) [condensed summary of the P Sander affiliations, the leading number and the color conveys importance]

₁Institut für Medizinische Mikrobiologie, Universität Zürich, Gloriastrasse 30/32, CH-8028 Zürich, Schweiz.
₁Department of Dermatology, Ruhr-University Bochum, Gudrunstr, Germany.

Key Opinion Leader In [P Sander is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (30) [keywords assigned to P Sander articles by PubMed, the leading number and the color conveys importance]

₁Macrophages | ₁Mycobacterium tuberculosis | ₁Tuberculosis | ₁AIDS-Related Opportunistic Infections | ₁Animals | ₁Anti-Bacterial Agents | ₁Cytochrome P-450 Enzyme System | ₁Lung | ₁Virulence | ₁Hydrocortisone | ₁Humans | ₁Transferases | ₁Candidiasis | ₁Mice, Inbred BALB C | ₁Amphotericin B | ₁Bacterial Proteins | ₁Immunocompromised Host | ₁Chromatography, High Pressure Liquid | ₁Esophagitis | ₁Protein Processing, Post-Translational | ₁Lipoproteins | ₁Mice | ₁Female | ₁Protein Precursors | ₁Aspartic Endopeptidases | ₁Genes, Bacterial | ₁Cell Line | ₁Mutagenesis, Insertional | ₁Antipyrine | ₁17-Hydroxycorticosteroids

P Sander Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; P Sander might be a good expert witness on these terms]

₁₀min | ₁₀ml | ₈vs | ₆lipoprotein | ₅tuberculosis | ₅lspa | ₄hiv-infected | ₄processing | ₄bacterial | ₄patients | ₄virulence | ₃cytochrome | ₃mycobacterium | ₃system | ₃decrease | ₂signal | ₂required | ₂amphotericin | ₂results | ₂impact | ₂study | ₂inhibitor | ₂pathogenesis | ₂role | ₂p450 | ₂clearance | ₂24h | ₂microg | ₂mg | ₂antipyrine | ₁growth | ₁found
₈ml min | ₄hiv-infected patients | ₄vs ml | ₄min vs | ₃lipoprotein processing | ₃mycobacterium tuberculosis | ₂required virulence | ₂cytochrome p450 | ₂lipoprotein signal | ₂processing required | ₂p450 system | ₂impact amphotericin | ₂system hiv-infected | ₂virulence mycobacterium | ₂amphotericin cytochrome | ₂mg min | ₂min ml | ₂min decrease | ₂microg 24h | ₁proteinase inhibitor | ₁pathogens despite | ₁am-b therapy | ₁half-life vs | ₁subgroup secreted | ₁ml decrease | ₁vs area | ₁vitro culture | ₁system seems | ₁determinant tuberculosis | ₁min 4-hydroxyantipyrine | ₁lipoprotein metabolism | ₁4-hydroxyantipyrine ml
₄vs ml min | ₄ml min vs | ₄min vs ml | ₂processing required virulence | ₂required virulence mycobacterium | ₂lipoprotein processing required | ₂virulence mycobacterium tuberculosis | ₂cytochrome p450 system | ₂p450 system hiv-infected | ₂system hiv-infected patients | ₂impact amphotericin cytochrome | ₂amphotericin cytochrome p450 | ₂mg min ml | ₂ml min decrease | ₁clearance ml min | ₁presence impermeable lipid | ₁findings establish lipoprotein | ₁ml min hydroxymethylantipyrine | ₁pathogens despite presence | ₁lipoprotein signal peptidase | ₁mycobacterium tuberculosis world | ₁antipyrine half-life vs | ₁therapy inhibitory effect | ₁bacterial proteins characterized | ₁lipidated n-terminus processing | ₁min ml decrease | ₁study lspa function | ₁urinary 6-beta-hydroxycortisol excretion | ₁lspa allelic replacement | ₁transferase lgt lipoprotein | ₁6-beta-hydroycortisol 17-hydroxycorticosteroids vs | ₁vs microg 24h

Reader's Comments (0) [comments posted by readers of P Sander profile]